UCHealthUCHealth Facebook ad: “Retatrutide, the newest weight-loss drug, helped people…”
Ran for 4 days, from July 9 to July 13, 2026, the last day Crush saw it.
Run by UCHealth on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 2113286212930998
- Platforms
- Relaunches
- 1
Ad text
A new weight-loss drug called retatrutide is generating excitement after clinical trial participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also found improvements in conditions like sleep apnea and knee pain. Retatrutide is still under review, but experts say it could mark the next major breakthrough in obesity treatment.
Where the ad sends people
uchealth.org
Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery
Retatrutide, a new weight-loss drug, helped people lose 30% of their body weight in a study, rivaling results seen with weight-loss surgery.
Open the advertiser's link: uchealth.org(opens in a new tab)
